MCID: CNV002
MIFTS: 40

Conversion Disorder

Categories: Rare diseases, Mental diseases, Neuronal diseases

Aliases & Classifications for Conversion Disorder

MalaCards integrated aliases for Conversion Disorder:

Name: Conversion Disorder 12 50 42 14 69
Hysterical Neurosis, Conversion Type 12
Functional Neurological Disorder 50
Conversion Hysteria or Reaction 12
Conversion Hysterical Neurosis 12
Functional Movement Disorder 50
Dissociative Disorder 69
Fnd 50

Classifications:



External Ids:

Disease Ontology 12 DOID:1768
ICD10 33 F44
ICD9CM 35 300.11
MeSH 42 D003291
UMLS 69 C0009946

Summaries for Conversion Disorder

NIH Rare Diseases : 50 conversion disorder is a disorder in which a person experiences blindness, paralysis, or other symptoms affecting the nervous system that cannot be explained solely by a physical illness or injury. symptoms usually begin suddenly after a period of emotional or physical distress or psychological conflict. conversion disorder is thought to be caused by the body’s reaction to a stressful physical or emotional event. some research has identified potential neurological changes that may be related to symptoms of the disorder. diagnosis of conversion disorder is based on identifying particular signs that are common among people with the disorder, as well as performing tests to rule out other causes of the symptoms. treatment may include psychotherapy, hypnosis, and stress management training to help reduce symptoms. treatment of any underlying psychological disorder is also recommended. the affected body part may require physical or occupational therapy until symptoms resolve. last updated: 8/18/2017

MalaCards based summary : Conversion Disorder, also known as hysterical neurosis, conversion type, is related to frontonasal dysplasia 1 and psychogenic movement, and has symptoms including waxy flexibility An important gene associated with Conversion Disorder is COMT (Catechol-O-Methyltransferase), and among its related pathways/superpathways is Biogenic Amine Synthesis. The drugs Everolimus and Miconazole have been mentioned in the context of this disorder. Affiliated tissues include kidney, liver and testes, and related phenotype is respiratory system.

Disease Ontology : 12 A somatoform disorder that involves numbness, blindness, paralysis or fits without a neurological cause.

Wikipedia : 72 Conversion disorder (CD) is a diagnostic category used in some psychiatric classification systems. It is... more...

Related Diseases for Conversion Disorder

Diseases related to Conversion Disorder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 54)
id Related Disease Score Top Affiliating Genes
1 frontonasal dysplasia 1 11.7
2 psychogenic movement 11.1
3 six2-related frontonasal dysplasia 10.8
4 dissociative disorder 10.6
5 chitty hall webb syndrome 10.1 COMT GAD1
6 bone fracture 10.0 COMT GAD1
7 dissociative amnesia 10.0
8 lymphoma 9.9
9 otospondylomegaepiphyseal dysplasia 9.9 ALX3 COMT
10 personality disorder 9.9 COMT GAD1
11 alexithymia 9.8
12 anorexia nervosa 9.7
13 reflex sympathetic dystrophy 9.7
14 chronic conjunctivitis 9.7 COMT GAD1
15 epilepsy 9.6
16 hemiplegia 9.6
17 pulmonary hypertension 9.5
18 addison's disease 9.5
19 somatization disorder 9.5
20 chronic pain 9.5
21 ptosis 9.5
22 foot drop 9.5
23 thrombosis 9.5
24 anxiety disorder 9.5
25 head injury 9.5
26 sensorineural hearing loss 9.5
27 astrocytoma 9.5
28 complex regional pain syndrome 9.5
29 tremor 9.5
30 cerebritis 9.5
31 serotonin syndrome 9.5
32 multiple chemical sensitivity 9.5
33 west nile virus 9.5
34 tetanus 9.5
35 spinal cord astrocytoma 9.5
36 epidural abscess 9.5
37 paraplegia 9.5
38 creutzfeldt-jakob disease 9.5
39 myopia 9.5
40 acute disseminated encephalomyelitis 9.5
41 incontinentia pigmenti 9.5
42 arachnoiditis 9.5
43 myeloid leukemia 9.5
44 locked-in syndrome 9.5
45 learning disability 9.5
46 guillain-barre syndrome 9.5
47 arachnoid cysts 9.5
48 brain injury 9.5
49 hypochondriasis 9.5
50 pandas 9.5

Comorbidity relations with Conversion Disorder via Phenotypic Disease Network (PDN):


Acute Cystitis Anxiety Disorder
Dysthymic Disorder Esophagitis
Hypertension, Essential Hypothyroidism
Schizophreniform Disorder Transient Cerebral Ischemia

Graphical network of the top 20 diseases related to Conversion Disorder:



Diseases related to Conversion Disorder

Symptoms & Phenotypes for Conversion Disorder

UMLS symptoms related to Conversion Disorder:


waxy flexibility

MGI Mouse Phenotypes related to Conversion Disorder:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 respiratory system MP:0005388 8.8 ALX3 COMT GAD1

Drugs & Therapeutics for Conversion Disorder

Drugs for Conversion Disorder (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 498)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Everolimus Approved Phase 4,Phase 3,Phase 2,Phase 1 159351-69-6 6442177
2
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1 22916-47-8 4189
3
Sirolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 53123-88-9 5284616 6436030 46835353
4
Tacrolimus Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 104987-11-3 445643 439492
5
Oseltamivir Approved Phase 4 204255-11-8, 196618-13-0 65028
6
Dopamine Approved Phase 4,Phase 3,Phase 2 51-61-6, 62-31-7 681
7
Pramipexole Approved, Investigational Phase 4,Phase 3 104632-26-0 59868 119570
8
Ropinirole Approved, Investigational Phase 4,Phase 3 91374-20-8, 91374-21-9 5095 497540
9
Mycophenolate mofetil Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2 128794-94-5 5281078
10
Mycophenolic acid Approved Phase 4,Phase 3,Phase 1,Phase 2 24280-93-1 446541
11
Prednisone Approved, Vet_approved Phase 4,Phase 2,Phase 3 53-03-2 5865
12
Omeprazole Approved, Investigational, Vet_approved Phase 4 73590-58-6 4594
13
Pantoprazole Approved Phase 4 102625-70-7 4679
14
Levofloxacin Approved, Investigational Phase 4,Phase 3 100986-85-4 149096
15
Ofloxacin Approved Phase 4,Phase 3 82419-36-1 4583
16
Ranibizumab Approved Phase 4,Phase 2,Phase 3,Phase 1 347396-82-1 459903
17
Citalopram Approved Phase 4,Phase 2,Phase 3 59729-33-8 2771
18
Triamcinolone Approved, Vet_approved Phase 4,Phase 3 124-94-7 31307
19
Sertraline Approved Phase 4 79617-96-2 68617
20
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
21
Gatifloxacin Approved, Investigational Phase 4 112811-59-3 5379
22
Gemifloxacin Approved, Investigational Phase 4 175463-14-6 5464436 9571107
23
Moxifloxacin Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 354812-41-2, 151096-09-2 152946
24
Norfloxacin Approved Phase 4 70458-96-7 4539
25
Methylphenidate Approved, Investigational Phase 4 113-45-1 4158
26
Benzocaine Approved Phase 4,Phase 3,Phase 2 1994-09-7, 94-09-7 2337
27
Antazoline Approved Phase 4 91-75-8 2200
28
Histamine Approved, Investigational Phase 4,Phase 1,Phase 2 75614-87-8, 51-45-6 774
29
Bicalutamide Approved Phase 4 90357-06-5 56069 2375
30
Dutasteride Approved, Investigational Phase 4,Phase 2 164656-23-9 152945 6918296
31
Haloperidol Approved Phase 4 52-86-8 3559
32
Atropine Approved, Vet_approved Phase 4 5908-99-6, 51-55-8 174174
33
Donepezil Approved Phase 4,Phase 3 120014-06-4 3152
34
Norepinephrine Approved Phase 4 51-41-2 439260
35
Pioglitazone Approved, Investigational Phase 4 111025-46-8 4829
36
Rosiglitazone Approved, Investigational Phase 4 122320-73-4 77999
37
Fluoxetine Approved, Vet_approved Phase 4 54910-89-3 3386
38
Amiodarone Approved, Investigational Phase 4,Phase 3 1951-25-3 2157
39
Darbepoetin alfa Approved, Investigational Phase 4,Phase 3,Phase 2 11096-26-7, 209810-58-2
40
Iron Approved Phase 4,Early Phase 1 7439-89-6 23925
41
Loperamide Approved Phase 4 53179-11-6 3955
42
Insulin Glargine Approved Phase 4 160337-95-1
43
Zinc Approved Phase 4 7440-66-6 32051 23994
44
Acetylcysteine Approved, Investigational Phase 4,Phase 2 616-91-1 12035
45
Heparin Approved, Investigational Phase 4,Phase 3 9005-49-6 772 46507594
46
Probucol Approved Phase 4 23288-49-5 4912
47
Azathioprine Approved Phase 4 446-86-6 2265
48
Galantamine Approved Phase 4,Phase 3 357-70-0 9651
49
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3 83-43-2 6741
50
Prednisolone Approved, Vet_approved Phase 4,Phase 3 50-24-8 5755

Interventional clinical trials:

(show top 50) (show all 429)

id Name Status NCT ID Phase Drugs
1 On-label tReatment With Intravitreal Aflibercept injectiOn for Patients With Persistent Pigment epitheliaL Detachments in Neovascular Age Related Macular Degeneration (AMD) Unknown status NCT01670162 Phase 4 Aflibercept
2 Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion Unknown status NCT00443508 Phase 4 adding Certican to therapy;reducing Tacrolimus
3 Characterisation of the Human Carboxylesterase 1 (CES1) Mutations in Thailand Unknown status NCT01443806 Phase 4 Oseltamivir
4 Study to Observe the Effect of Mirapex ER® Once-daily (QD) Versus Twice-daily (BID) Unknown status NCT01515774 Phase 4 Mirapex ER
5 Efficacy of Certican® in Combination With Myfortic® in Renal Unknown status NCT01399242 Phase 4 Certican
6 Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients Unknown status NCT00999258 Phase 4 sirolimus
7 "Pharmacodynamic Comparison of Omeprazole Versus Pantoprazole on Platelet Reactivity in Patients With Acute Coronary Syndromes on Dual Antiplatelet Therapy With New P2Y12 Inhibitors" -Trial dOPPLER- Unknown status NCT02028234 Phase 4 Pantoprazole,;Omeprazole
8 Targeted Indoor Residual Spraying Against Malaria Unknown status NCT02556242 Phase 4
9 Treatments for Psychogenic Nonepileptic Seizures (NES) Completed NCT00159965 Phase 4 sertraline;placebo
10 Treatment Trial for Psychogenic Nonepileptic Seizures Completed NCT00835627 Phase 4 sertraline
11 An Observational Study of Oral Fluoroquinolones and the Risk of Retinal Detachment Completed NCT01881438 Phase 4
12 Intravitreal Aflibercept Injection for the Treatment of Submacular Vascularized Pigment Epithelial Detachment Completed NCT01722656 Phase 4 Aflibercept
13 Intravitreal Ranibizumab in Retinal Pigment Epithelial Detachments Completed NCT00976222 Phase 4 intravitreal injection with ranibizumab
14 Eylea to Treat Retinal Pigment Epithelial Detachment (RPED) Secondary to Wet Age-Related Macular Degeneration (wAMD) Completed NCT02142296 Phase 4 Eylea
15 A Study to Determine Effective and Tolerable Titration Scheme for OROS-Methylphenidate in Children With Attention-deficit Hyperactivity Disorder Completed NCT00518232 Phase 4 OROS-methylphenidate
16 The Role of Vitamin D in Immune Function in Patients With Chronic Kidney Disease (CKD) Stages 3 and 4. Completed NCT00749736 Phase 4
17 Study to Compare the Effect of Ropinirole Prolonged Release Once-daily Versus Twice-daily Completed NCT00986245 Phase 4 Ropinirole Prolonged release
18 The Vienna Prograf and Endothelial Progenitor Cell Study Completed NCT00182559 Phase 4 Ciclosporin;Tacrolimus
19 A Study of EGb 761® (Tanakan®) in Dementia of Alzheimer Type Onset in Patients Suffering From Memory Complaints Completed NCT00276510 Phase 4 EGb 761® (Tanakan®)
20 A Phase 4 Study to Determine Dosing of Hectorol® Capsules When Converting From Zemplar® Injection Completed NCT00463021 Phase 4 Hectorol (doxercalciferol capsules);Zemplar (paricalcitol injection)
21 Antazoline in Rapid Cardioversion of Paroxysmal Atrial Fibrillation Completed NCT01527279 Phase 4 antazoline;0.9% saline
22 Once-a-day Immunosuppression(CISECON_a_day) Completed NCT01964014 Phase 4 advagrf
23 Study on Costs and Safety of Early Conversion From Intravenous to Oral Antibiotic Treatment in Patients With Severe Community-Acquired Pneumonia Completed NCT00273676 Phase 4
24 Prostate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation Therapy Completed NCT00470834 Phase 4 dutasteride;placebo;bicalutamide
25 Preventing ICU Subsyndromal Delirium Conversion to Delirium With Haloperidol Completed NCT01174290 Phase 4 Haloperidol decanoate;Placebo
26 A Phase 4, Conversion Study of Hectorol® Injection to Hectorol® Capsules in Stage 5 CKD Patients on Dialysis Completed NCT00418600 Phase 4 Hectorol® (doxercalciferol capsules);doxercalciferol capsules, Hectorol®;doxercalciferol capsules, Hectorol® capsules
27 Olfactory Deficits in MCI as Predictor of Improved Cognition on Donepezil Completed NCT01845636 Phase 4 Donepezil;Atropine
28 Pharmacokinetic Study Of Valaciclovir Hydrochloride Tablets Completed NCT00343278 Phase 4 Valaciclovir Hydrochloride
29 Combination Treatment Study for Memory Impairment and Depression Completed NCT01658228 Phase 4 Donepezil;Placebo;Citalopram;Venlafaxine
30 Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines Completed NCT01270503 Phase 4
31 Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone. Completed NCT00672919 Phase 4 Pioglitazone
32 Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients Completed NCT00369382 Phase 4 cyclosporine or tacrolimus;sirolimus
33 Prevention of Relapse & Recurrence of Bipolar Depression Completed NCT00961961 Phase 4 Lithium / Fluoxetine;Lithium / Placebo
34 A Trial Comparing Deep Versus Moderate Neuromuscular Block - in Low Pressure Pneumoperitoneum Completed NCT02602964 Phase 4
35 Endo-Laparoscopic Approach Versus Conventional Open Surgery in Obstructing Left-sided Colon Cancer: RCT Completed NCT00654212 Phase 4
36 Atrial Fibrillation Without Hemodynamic Instability in the Intensive Care Unit Completed NCT01461733 Phase 4 amiodarone;Placebo
37 Cost Comparison Study of Darbepoetin Versus Epoetin Therapy to Treat Anemia in Hemodialysis Patients Completed NCT02817555 Phase 4 Epoetin Alfa;Darbepoetin alfa
38 Insulin Secretion and Advagraf Completed NCT01092806 Phase 4 Tacrolimus
39 Cholesterol Lowering Treatment With Psyllium Husks and Isolated Soy Protein in Hypercholesterolemia Completed NCT01251991 Phase 4 Psyllium husks
40 Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant Completed NCT00171717 Phase 4 Cyclosporine - cyclosporine microemulsion
41 Conversion of Hyperglycemic Patients Being Treated With Intravenous Insulin Infusions to Lantus Insulin Completed NCT00338104 Phase 4 insulin glargine;insulin glargine;insulin glargine
42 Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion Completed NCT00188773 Phase 4 N-acetylcysteine, intralipid, heparin
43 Effects of Atorvastatin Versus Probucol on Small Dense LDL Completed NCT00276133 Phase 4 Effects of atorvastatin versus probucol on small dense LDL
44 Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients Completed NCT01624948 Phase 4 Everolimus;Mycophenolic acid dose reduction
45 Rasagiline (Azilect) - Neuroprotection for Macula-off Retinal Detachment Recruiting NCT02068625 Phase 4 Rasagiline;Placebo
46 Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence Recruiting NCT02671318 Phase 4 Drug conversion to sirolimus;Maintenance of the current regimen
47 Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study) Recruiting NCT02947438 Phase 4 EPREX®;EPIAO®
48 Efficacy and Safety of Qinggongshoutao Bolus in aMnestic Mild Cognitive Impairment Recruiting NCT02982603 Phase 4 Qinggongshoutao Bolus;Ginkgo Biloba Extract 761;Placebos
49 Olfactory Deficits and Donepezil Treatment in Cognitively Impaired Elderly Recruiting NCT01951118 Phase 4 Donepezil
50 Belatacept 3 Month Post Transplant Conversion Study Recruiting NCT02213068 Phase 4 belatacept;Tacrolimus;MPA

Search NIH Clinical Center for Conversion Disorder

Cochrane evidence based reviews: conversion disorder

Genetic Tests for Conversion Disorder

Anatomical Context for Conversion Disorder

MalaCards organs/tissues related to Conversion Disorder:

39
Kidney, Liver, Testes, Eye, Prostate, Brain, Endothelial

Publications for Conversion Disorder

Articles related to Conversion Disorder:

(show top 50) (show all 316)
id Title Authors Year
1
Conversion disorder: A systematic review of current terminology. ( 28274339 )
2017
2
Conversion Disorder, Functional Neurological Symptom Disorder, and Chronic Pain: Comorbidity, Assessment, and Treatment. ( 28434123 )
2017
3
Are psychogenic non-epileptic seizures just another symptom of conversion disorder? ( 28235779 )
2017
4
Postoperative Conversion Disorder Presenting as Inspiratory Stridor and Hemiparesis in a Pediatric Patient. ( 28093564 )
2017
5
La belle indiffAcrence revisited: a case report on progressive supranuclear palsy misdiagnosed as conversion disorder. ( 28814874 )
2017
6
A Case of Sporadic Creutzfeldt-Jakob Disease Presenting as Conversion Disorder. ( 28553554 )
2017
7
Downwards Vertical Attention Bias in Conversion Disorder vs Controls: A Pilot Study. ( 28844417 )
2017
8
Conversion disorder or multiple sclerosis? ( 28784382 )
2017
9
Conversion Disorder Comorbidity and Childhood Trauma. ( 28566953 )
2017
10
Psychometric properties of Conversion Disorder Scale- Revised (CDS) for children. ( 28507360 )
2017
11
Symptom-specific amygdala hyperactivity modulates motor control network in conversion disorder. ( 28529870 )
2017
12
The classification of conversion disorder (functional neurologic symptom disorder) in ICD and DSM. ( 27719838 )
2017
13
Postoperative transient blindness after general anesthesia and surgery: case report of conversion disorder. ( 28936911 )
2017
14
The role of psychiatrists in diagnosing conversion disorder: a mixed-methods analysis. ( 27274253 )
2016
15
Functional Neuroanatomy and Neurophysiology of Functional Neurological Disorders (Conversion Disorder). ( 26900733 )
2016
16
Clinical Considerations Regarding Regression in Psychotherapy with Patients with Conversion Disorder. ( 27603802 )
2016
17
Sense of body ownership in patients affected by functional motor symptoms (conversion disorder). ( 26704189 )
2016
18
Demonstration of Injury of the Corticospinal Tract in a Patient with Suspected Motor Conversion Disorder. ( 27386816 )
2016
19
Relationships among depression, anxiety, anxiety sensitivity, and perceived social support in adolescents with conversion disorder. ( 26824691 )
2016
20
Childhood Trauma and Alexithymia in Patients with Conversion Disorder. ( 27504555 )
2016
21
Postoperative conversion disorder. ( 27041258 )
2016
22
Aversive stimuli exacerbate defensive motor behaviour in motor conversion disorder. ( 27842291 )
2016
23
Uncovering the etiology of conversion disorder: insights from functional neuroimaging. ( 26834476 )
2016
24
Can motor imagery and hypnotic susceptibility explain Conversion Disorder with motor symptoms? ( 27346334 )
2016
25
Poster 173 Concussions Presenting with Conversion Disorder: AA Case Series. ( 27672938 )
2016
26
Evaluation of oxidant, antioxidant, and S100B levels in patients with conversion disorder. ( 27471386 )
2016
27
Conversion Disorder in an Appalachian Community. ( 27490651 )
2016
28
Interdisciplinary rehabilitation approach for functional neurological symptom (conversion) disorder: A case study. ( 26689100 )
2016
29
Neural correlates of conversion disorder: overview and meta-analysis of neuroimaging studies on motor conversion disorder. ( 27283002 )
2016
30
Cognitive Behavioural Therapy and Adjunctive Physical Activity for Functional Movement Disorders (Conversion Disorder): A Pilot, Single-Blinded, Randomized Study. ( 27744440 )
2016
31
From conversion disorder (DSM-IV-TR) to functional neurological symptom disorder (DSM-5): When a label changes the perspective for the neurologist, the psychiatrist and the patient. ( 26723973 )
2016
32
Erratum: Uncovering the etiology of conversion disorder: insights from functional neuroimaging [Corrigendum]. ( 27103807 )
2016
33
Functional networks of motor inhibition in conversion disorder patients and feigning subjects. ( 27330971 )
2016
34
Life events and escape in conversion disorder. ( 27377290 )
2016
35
Poster 294 Conversion Disorder Rehabilitation: A Case Report. ( 27673051 )
2016
36
Conversion Disorder- Mind versus Body: A Review. ( 26155375 )
2015
37
Efficacy of brief interdisciplinary psychotherapeutic intervention for motor conversion disorder and nonepileptic attacks. ( 26099544 )
2015
38
Recurrence of conversion disorder symptoms in a successfully treated 16-year-old female. ( 26510710 )
2015
39
Pituitary volumes are changed in patients with conversion disorder. ( 25877743 )
2015
40
Conversion disorder in a preschool age girl. ( 25972349 )
2015
41
Cognitive-analytical therapy for a patient with functional neurological symptom disorder-conversion disorder (psychogenic myopia): A case study. ( 26487881 )
2015
42
An atypical presentation of visual conversion disorder. ( 25744066 )
2015
43
Hospital revisit rate after a diagnosis of conversion disorder. ( 25855400 )
2015
44
Knowledge of conversion disorder in children by pediatricians in a developing country. ( 25966728 )
2015
45
P-wave and QT dispersion in patients with conversion disorder. ( 25848293 )
2015
46
Somatoform and Conversion Disorder Preceding Lewy Body Dementia: A Newly Described Phenomenological Manifestation of the Disease. ( 26390000 )
2015
47
Paralympics and conversion disorder. ( 25948495 )
2015
48
Conversion Disorder; an Unusual Etiology of Unilateral Foot Drop. ( 26179836 )
2015
49
Group Dialectical-Behavior Therapy Skills Training for Conversion Disorder With Seizures. ( 25959039 )
2015
50
Emotion-motion interactions in conversion disorder: an FMRI study. ( 25859660 )
2015

Variations for Conversion Disorder

Expression for Conversion Disorder

Search GEO for disease gene expression data for Conversion Disorder.

Pathways for Conversion Disorder

Pathways related to Conversion Disorder according to GeneCards Suite gene sharing:

id Super pathways Score Top Affiliating Genes
1
Show member pathways
9.97 COMT GAD1

GO Terms for Conversion Disorder

Sources for Conversion Disorder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....